We are live on ! Find out more
LOIM

Liberty One Investment Management Portfolio holdings

AUM $970M
1-Year Est. Return 12.15%
This Fund
S&P 500
This Quarter Est. Return
+4.89%
1 Year Est. Return
+12.15%
3 Year Est. Return
+38.77%
5 Year Est. Return
+56.87%
10 Year Est. Return
AUM
$561M
AUM Growth
+$29.3M
Cap. Flow
+$9.66M
Cap. Flow %
1.72%
Top 10 Hldgs %
34.75%
Holding
146
New
10
Increased
91
Reduced
41
Closed
4

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$10.5M
2
BCE icon
BCE
BCE
+$10.4M
3
INGR icon
Ingredion
INGR
+$9.71M
4
DOX icon
Amdocs
DOX
+$7.09M
5
MSFT icon
Microsoft
MSFT
+$6.78M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$17.2M
2
MKC icon
McCormick & Company Non-Voting
MKC
+$15.3M
3
K
Kellanova
K
+$10.4M
4
KDP icon
Keurig Dr Pepper
KDP
+$4.94M
5
LLY icon
Eli Lilly
LLY
+$2.86M

Sector Composition

Rank Sector Weight
1 Consumer Staples 30.99%
2 Healthcare 17.07%
3 Utilities 13.49%
4 Industrials 11.87%
5 Consumer Discretionary 7.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTR icon
126
Nutrien
NTR
$32.1B
$192K 0.03%
3,563
-156
-4% -$8.48K
TGTX icon
127
TG Therapeutics
TGTX
$7.58B
$172K 0.03%
3,573
-67
-2% -$3.22K
CHWY icon
128
Chewy
CHWY
$9.15B
$169K 0.03%
1,998
+925
+86% +$90K
LTHM
129
DELISTED
Livent Corporation
LTHM
$164K 0.03%
9,465
+2,227
+31% +$43.7K
NOW icon
130
ServiceNow
NOW
$129B
$163K 0.03%
1,630
+525
+48% +$55.4K
KRYS icon
131
Krystal Biotech
KRYS
$9.85B
$162K 0.03%
2,102
+545
+35% +$39.6K
CRSP icon
132
CRISPR Therapeutics
CRSP
$5.22B
$158K 0.03%
1,297
+339
+35% +$51.2K
MDGL icon
133
Madrigal Pharmaceuticals
MDGL
$12.4B
$158K 0.03%
1,352
+685
+103% +$79.9K
ESTC icon
134
Elastic
ESTC
$8.02B
$153K 0.03%
1,372
+444
+48% +$63.1K
PLTR icon
135
Palantir
PLTR
$411B
$152K 0.03%
6,536
+3,514
+116% +$96.4K
TWLO icon
136
Twilio
TWLO
$37.9B
$149K 0.03%
438
+67
+18% +$25.1K
K
137
DELISTED
Kellanova
K
$143K 0.03%
2,412
-186,321
-99% -$10.4M
LMT icon
138
Lockheed Martin
LMT
$140B
$142K 0.03%
384
+22
+6% +$7.55K
WW
139
DELISTED
WW International
WW
$142K 0.03%
4,526
+1,849
+69% +$53.3K
PRVB
140
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$139K 0.02%
13,200
+5,620
+74% +$79.1K
STNE icon
141
StoneCo
STNE
$2.43B
$136K 0.02%
2,221
+587
+36% +$45.8K
MKC icon
142
McCormick & Company Non-Voting
MKC
$14.2B
$94K 0.02%
1,051
-172,358
-99% -$15.3M
ARWR icon
143
Arrowhead Research
ARWR
$12.3B
-1,886
Closed -$145K
TMO icon
144
Thermo Fisher Scientific
TMO
$223B
-253
Closed -$118K
TTD icon
145
Trade Desk
TTD
$6.34B
-1,400
Closed -$112K
WDAY icon
146
Workday
WDAY
$43.3B
-525
Closed -$126K

Similar funds

Liberty One Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, Liberty One Investment Management held 146 positions worth $561M, up 5.5% from $532M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Liberty One Investment Management's Q1 2021 filing shows 10 new, 91 increased, 41 reduced and 4 closed positions. Its largest new stake was Gilead Sciences: 162,671 shares worth $10.5M. The largest sale was AT&T, an estimated $17.2M.

By sector, the portfolio is most concentrated in Consumer Staples at 31% of assets, down from 36% a quarter earlier, followed by Healthcare and Utilities.

  • Liberty One Investment Management's largest Q1 2021 buy was Gilead Sciences: 162,671 shares worth $10.5M.
  • Liberty One Investment Management added most to BCE in Q1 2021, an estimated $10.4M increase.
  • Liberty One Investment Management's biggest Q1 2021 reduction was AT&T, cutting an estimated $17.2M.
  • Liberty One Investment Management fully exited Arrowhead Research in Q1 2021, selling an estimated $145K.
  • Liberty One Investment Management's ten largest holdings make up 35% of its $561M portfolio in Q1 2021.
  • Liberty One Investment Management opened 10 new positions and closed 4 in Q1 2021.
  • Liberty One Investment Management's portfolio value rose 5.5% quarter-over-quarter to $561M.

Based on Liberty One Investment Management's 13F filing for Q1 2021, filed 6 Apr 2021.